Universal Vision Biotechnology Co (ROCO:3218) LT-Debt-to-Total-Asset : 0.14 (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Universal Vision Biotechnology Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.14.

Universal Vision Biotechnology Co's long-term debt to total assets ratio increased from Sep. 2023 (0.13) to Dec. 2024 (0.14). It may suggest that Universal Vision Biotechnology Co is progressively becoming more dependent on debt to grow their business.

Universal Vision Biotechnology Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Universal Vision Biotechnology Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Vision Biotechnology Co LT-Debt-to-Total-Asset Chart

Universal Vision Biotechnology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.10

0.17

0.14

0.12

0.14

Universal Vision Biotechnology Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.13	0.12	0.13	0.12	0.14

Universal Vision Biotechnology Co LT-Debt-to-Total-Asset Calculation

Universal Vision Biotechnology Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	783.828	/	5762.702
	=	0.14

Universal Vision Biotechnology Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	783.828	/	5762.702
	=	0.14

Universal Vision Biotechnology Co (ROCO:3218) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Universal Vision Biotechnology Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Vision Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.uvb.com.tw

Universal Vision Biotechnology Co Ltd is mainly engaged in operating the business of (1) sales of optical devices, glasses, lens and other vision aid products (2) optometric services (3) sales and leasing of medical devices (4) providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co Headlines

No Headlines